ClinicalTrials.Veeva

Menu

Level of Physical Activity and Fear Learning

NYU Langone Health logo

NYU Langone Health

Status

Enrolling

Conditions

Panic Disorder
Generalized Anxiety Disorder
Social Anxiety Disorder

Treatments

Behavioral: Exercise
Behavioral: Sitting

Study type

Interventional

Funder types

Other

Identifiers

NCT05203731
21-01657

Details and patient eligibility

About

The proposed experimental study will be the first to investigate whether exercise vs. sitting enhances consolidation of extinction learning in adults with high AS and anxiety disorders, and the mechanistic pathways of expectancy, affect, and key stress response markers.

Full description

This is an experimental study (not a treatment study) aiming to examine the effects of acute exercise vs. sitting on fear extinction learning in a 2-day paradigm. 50 eligible (after screening) men and women ages 18-60 with high anxiety sensitivity (AS) and an anxiety disorder (generalized anxiety disorder, panic disorder, social anxiety disorder) will participate in a consecutive 2-day paradigm. Participants will be randomized to 1 of 2 conditions immediately following the emotional learning paradigm: 1) moderate intensity exercise (n=25) or 2) sitting(n=25), for 20 minutes. Day 2 will include testing of emotional learning. Primary outcomes are physiological arousal (skin conductance, heart rate) during Day 2 procedures. Mechanistic factors, including expected negative consequences of exercise, affect during exercise, threat/shock expectancy, and changes pre-post exercise in stress related neuroendocrine markers (cortisol and alpha-amylase) and their effects on extinction recall will be measured.

Enrollment

50 estimated patients

Sex

All

Ages

18 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Males and females ages 18-60
  • A primary diagnosis of a DSM-5 anxiety disorder (generalized anxiety disorder, panic disorder, social anxiety disorder)
  • Anxiety Sensitivity Index-3 score of ≥23 (i.e., high anxiety sensitivity)
  • Able and willing to provide informed consent

Exclusion criteria

  • Lifetime Bipolar Disorder or psychosis
  • Past 3 months substance use disorder or eating disorder
  • Current PTSD (past PTSD > 6 months prior to screening is allowed)
  • High risk for exercise according to the Physical Activity Readiness Questionnaire and American College of Sports Medicine guidelines with excluded active medical conditions including heart conditions, lung disease, bone/joint problems, or seizures
  • Women who are currently pregnant
  • Acute suicide risk (active suicidal ideation with plan and intent) as indicated by a score of ≥4 on the Columbia Suicide Severity Rating Scale (C-SSRS)
  • Benzodiazepine use
  • Current substance abuse or positive urine toxicology screen (recreational use of marijuana is permitted based on clinical assessment on the MINI structured diagnostic interview that it does not meet criteria for cannabis use disorder)
  • Stable psychiatric medications for at least 4 weeks prior to experimental procedures

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

50 participants in 2 patient groups

Exercise Group
Experimental group
Description:
Participants who will be randomized to moderate intensity exercise after extinction (Day 1)
Treatment:
Behavioral: Exercise
Seated group
Sham Comparator group
Description:
Participants who will be randomized to sitting after extinction (Day 1)
Treatment:
Behavioral: Sitting

Trial contacts and locations

1

Loading...

Central trial contact

Giselle Cornejo; Kristin Szuhany, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems